SecBot SecBot
6-K ·Filed Jun 8, 2026

NYXH

Nyxoah SA
BEARISH
Impact 7/10
Horizonimmediate Processed4mo ago SEC0001104659-26-071359
Notable filing: 6-K
Actionable Insight ▼ Bearish

Massive dilution (~126% increase in share count) signals acute financial distress. Monitor for potential further capital needs post-closing and any impact on Nasdaq listing compliance. The offering price of $1.72 is a ~19% premium to the last close of $1.45, but the sheer dilution likely overwhelms any near-term price support. Watch for insider participation details and any subsequent guidance or operational updates.

DirectionBearish
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
NYXH ▲ +12.69% at T+60d
SHORT call ✗ call lost -12.69% · α vs SPY -8.87% · entry $1.34 → $1.51
Entry = T+0 close
Jun 8, 2026
via day close
T+1d
-2.24%
call +2.24% · α +0.66%
$1.31
settled 5mo ago
T+5d
+15.67%
call -15.67% · α -13.26%
$1.55
settled 4mo ago
T+20d
+25.37%
call -25.37% · α -23.93%
$1.68
settled 4mo ago
T+60d
+12.69%
call -12.69% · α -8.87%
$1.51
settled 8w ago

Price Chart

Loading chart...

Executive Summary

Nyxoah priced a $95M gross underwritten public offering of 55.2M ordinary shares at $1.72/share, representing ~126% dilution from the 43.7M shares outstanding as of March 31, 2026. Net proceeds are expected to be ~$88.5M. The filing also confirms the underwriting agreement and related legal opinions. This massive dilutive capital raise, coming just days after a preliminary prospectus and following a cash runway extending only into Q3 2026, signals acute financial distress and overshadows any positive commercial or regulatory developments.

Key Facts

  • Priced offering of 55,232,558 ordinary shares at $1.72/share, with an underwriter option for up to 8,284,883 additional shares.
  • Gross proceeds of ~$95M; net proceeds of ~$88.5M (€76.3M) after discounts and expenses.
  • Offering represents ~126% dilution relative to 43.7M shares outstanding as of March 31, 2026.
  • Company had only €25.9M in cash and financial assets as of Q1 2026, with cash runway extending only into Q3 2026.
  • Proceeds to fund US commercialization, R&D, and general corporate purposes; company also intends to draw €13.8M from EIB loan in Q2 2026.
  • Insider participation: Chairman Robert Taub, independent directors Jürgen Hambrecht and Kevin Rakin expressed interest to participate, subject to related-party procedure.
  • Offering expected to close June 9, 2026.

Financial Impact

~$88.5M net proceeds from a ~126% dilutive offering; company had €25.9M cash as of Q1 2026 with runway into Q3 2026.

dilutioncashdebt

Risk Factors

  • Extreme dilution (~126%) will pressure the stock price as new shares hit the market.
  • Cash runway only into Q3 2026 suggests additional capital raises may be needed, further diluting holders.
  • Accumulated deficit of €321.7M and ongoing operating losses raise going-concern risk.
  • IPR petitions against competitor Inspire were denied, weakening competitive positioning.
  • CEO transition to a U.S.-based successor adds leadership uncertainty.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
79% bullish (14 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001104659-26-071359
Document: tm2617103d1_ex5-1.htm0001104659-26-071359
Document: tm2617103d1_ex99-2.htm0001104659-26-071359
Document: tm2617103d1_ex99-1.htm0001104659-26-071359
Document: tm2617103d1_6k.htm0001104659-26-071359
Document: 0001104659-26-071359-index-headers.html0001104659-26-071359
Document: 0001104659-26-071359-index.html0001104659-26-071359
Document: 0001104659-26-071359.txt0001104659-26-071359
13 reports for NYXH
Performance horizon
67% Hit rate @ T+1 6 of 9 directional calls Went positive at some point 8 of 9 best @ T+1▲ +8.16%Oct 20, 2026
Filters
Rows
Reports for NYXH — sortable, filterable
TypeNow
Oct 20, 2026
5d ago
6-K
BEARISH ★ 6/10
$0.8950 $0.8220▲ +8.16%▲ +6.98%$0.8564 (+4.31%)
Oct 19, 2026
7d ago
Press Release
BEARISH ★ 6/10
$0.9540 $0.9400▲ +1.47%▲ +1.80%$0.8564 (+10.23%)
Sep 22, 2026
4w ago
6-K
NEUTRAL ★ 3/10
$1.33 $1.27▼ −4.51%▼ −4.43%$0.8564 (−35.61%)
Jun 23, 2026
17w ago
6-K
BEARISH ★ 6/10
$1.62 $1.63▼ −0.62%▼ −0.47%$0.8564 (+47.14%)
Jun 11, 2026
19w ago
6-K
BEARISH ★ 7/10
$1.39 $1.55▼ −11.51%▼ −9.75%$0.8564 (+38.39%)
Jun 8, 2026
20w ago
6-K
BEARISH ★ 7/10
$1.34 $1.31▲ +2.24%▲ +0.66%$0.8564 (+36.09%)
Jun 8, 2026
20w ago
424B5
BEARISH ★ 7/10
$1.39 $1.34▲ +3.60%▲ +3.30%$0.8564 (+38.39%)
Jun 5, 2026
20w ago
Press Release
BEARISH ★ 7/10
$1.45 $1.39▲ +4.14%▲ +4.36%$0.8564 (+40.94%)
Jun 4, 2026
20w ago
424B5
BEARISH ★ 7/10
$1.45 $1.39▲ +4.14%▲ +4.36%$0.8564 (+40.94%)
May 20, 2026
22w ago
Press Release
BULLISH ★ 5/10
$2.87 $2.87· 0.00%▼ −0.45%$0.8564 (−70.16%)
Showing 10 of 13

US Market Status

Market Closed — Opens Tue (17h 29m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 8, 2026